发明申请
US20100286088A1 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d][1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use
有权
3-取代-4-氧代-3,4-二氢咪唑并[5,1-d] [1,2,3,5-四嗪-8-羧酸酰胺及其用途
- 专利标题: 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d][1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use
- 专利标题(中): 3-取代-4-氧代-3,4-二氢咪唑并[5,1-d] [1,2,3,5-四嗪-8-羧酸酰胺及其用途
-
申请号: US12808604申请日: 2008-12-16
-
公开(公告)号: US20100286088A1公开(公告)日: 2010-11-11
- 发明人: Malcolm Francis Graham Stevens , David Cousin , Sharon Jennings , Andrew James McCarroll , John Gareth Williams , Marc Geoffery Hummersone , Jihong Zhang
- 申请人: Malcolm Francis Graham Stevens , David Cousin , Sharon Jennings , Andrew James McCarroll , John Gareth Williams , Marc Geoffery Hummersone , Jihong Zhang
- 申请人地址: GB Abingdon Oxfordshire
- 专利权人: PHARMINOX LIMITED
- 当前专利权人: PHARMINOX LIMITED
- 当前专利权人地址: GB Abingdon Oxfordshire
- 国际申请: PCT/GB08/04140 WO 20081216
- 主分类号: A61K31/4188
- IPC分类号: A61K31/4188 ; C07D487/04 ; A61K31/4545 ; A61K31/5377 ; C07F7/10 ; A61K31/695 ; A61K31/4245 ; A61K31/4192 ; C07F9/40 ; A61K31/683 ; A61P35/00
摘要:
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (collectively referred to herein as 3TM compounds). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit cell proliferation, and in the treatment of proliferative disorders such as cancer, etc., and methods of preparing such compounds.
公开/授权文献
信息查询
IPC分类: